Copy Link Print Information

iMDK quarterhydrate

7 Cited Publications
Revisión del cliente

Based on 7 publication(s) in Google Scholar

iMDK quarterhydrate is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.37%
  • Fòrmula: C21H13FN2O2S.1/4H2O
  • Peso molecular:380.91
  • Almacenamiento:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • iMDK quarterhydrate Chemical Structure
    iMDK quarterhydrate Chemical Structure
  • Experimental Validation Results for iMDK quarterhydrate
  • Experimental Validation Results for iMDK quarterhydrate
  • Experimental Validation Results for iMDK quarterhydrate
  • Experimental Validation Results for iMDK quarterhydrate
  • Experimental Validation Results for iMDK quarterhydrate
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of iMDK quarterhydrate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) iMDK quarterhydrate

More
Customer Validation & Images
In Vivo Efficacy StudyHistological Imaging/StainingRT-PCRCell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • In Vivo Efficacy Study
  • Histological Imaging/Staining
  • RT-PCR
  • Cell Proliferation/Viability Assay

Ver todos los productos específicos de isoformas PI3K

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • iMDK quarterhydrate Chemical Structure
    iMDK quarterhydrate Chemical Structure
    1/16
  • 1/16

    iMDK quarterhydrate purchased from MedChemExpress. Usage Cited in: Cell Discov. 2024 Oct 22;10(1):110. [Abstract]

    Customer Validation
     iMDK (9 mg/kg, intraperitoneally injected, once a day from E7.5 to E12.5.). Placental efficiency as expressed by the ratio of fetal weight to placental weight (n = 24 for control, n = 41 for iMDK).

  • 1/16

    iMDK quarterhydrate purchased from MedChemExpress. Usage Cited in: Cell Discov. 2024 Oct 22;10(1):110. [Abstract]

    Customer Validation
     iMDK (9 mg/kg, intraperitoneally injected, once a day from E7.5 to E12.5.). Measurements of the labyrinth area and JZ area and the ratio of the labyrinth area to the JZ area (n = 8 control, n = 14 iMDK).

  • 1/16

    iMDK quarterhydrate purchased from MedChemExpress. Usage Cited in: Cell Discov. 2024 Oct 22;10(1):110. [Abstract]

    Customer Validation
     iMDK (9 mg/kg, intraperitoneally injected, once a day from E7.5 to E12.5.). Representative image of a cross-section through the labyrinth and JZ in a mid-section of a mouse placenta. The blue solid line outlines the labyrinth and JZ that was measured.

  • 1/16

    iMDK quarterhydrate purchased from MedChemExpress. Usage Cited in: Cell Discov. 2024 Oct 22;10(1):110. [Abstract]

    Customer Validation
     iMDK (9 mg/kg, intraperitoneally injected, once a day from E7.5 to E12.5.). Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of the expression of markers of SynT-I (Mct1) and endothelial cells (Cd31). RT-qPCR data were normalized to the reference gene Hprt.

  • 1/16

    iMDK quarterhydrate purchased from MedChemExpress. Usage Cited in: Cell Discov. 2024 Oct 22;10(1):110. [Abstract]

    Customer Validation
     The CCK-8 assay was used to evaluate the proliferation of endothelial cells treated with iMDK (0.125-1 μM).

  • iMDK quarterhydrate